Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology
Interspec reported this month that its radiology ultrasound R&Dand marketing agreement with Siemens is off. The Ambler, PA, cardiacultrasound supplier had been working with the large German multimodalityimaging vendor to develop a radiology ultrasound scanner (SCAN10/24/90).
Siemens would have had international rights to market thescanner once it was developed. Interspec retains worldwide rightsto the technology developed cooperatively. The smaller firm plansto sell the system itself through a combination of direct salesand distribution agreements, according to Edward Ray, chairmanand CEO.
"Interspec will take advantage of this opportunity andexpand its established international distribution to market itsnew product when it becomes available," Ray said.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.